An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Conditions: Idiopathic Hypersomnia; Excessive Daytime Sleepiness Intervention: Drug: pitolisant Sponsor: Harmony Biosciences, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials
